Drug Shortage Report for TAMSULOSIN CR
| Report ID | 215019 |
| Drug Identification Number | 02413612 |
| Brand name | TAMSULOSIN CR |
| Common or Proper name | TAMSULOSIN CR |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30,500 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2024-08-31 |
| Actual start date | |
| Estimated end date | 2024-12-31 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-01-30 | English | Compare |
| v2 | 2024-01-05 | French | Compare |
| v1 | 2024-01-05 | English | Compare |
Showing 1 to 3 of 3